Skip to main content
. 2015 Oct 29;13(4):1559325815610760. doi: 10.1177/1559325815610760

Table 2.

P Value Summary for Analyses of Effect of Prenatal Negative Controls and BPA Doses (0, 5, 50, 500, 5000, and 50 000 µg/kg/d), not Including the DES-0.1 Group.a

Variable PROC GLM ANOVA Multilevel Regression
BPA Doses Improvement in Fit: Quadratic Over Linear-Only Model
Body weight
 Birth weight = 0.550 = 0.420
 Week 3 weight = 0.020 = 0.019
 Week 19 weight = 0.193 = 0.069
 Energy intake, week 3-4 = 0.358 = 0.033
Energy intake, week 4-5 = 0.201 = 0.028
Adipocytes
 Gonadal fat weight = 0.017 = 0.022
 Renal fat weight = 0.019 = 0.076
 Total abdominal fat weight = 0.035 = 0.047
 Gonadal adipocyte number = 0.003 = 0.002
 Gonadal adipocyte volume = 0.006 = 0.052
 Renal adipocyte number = 0.011 = 0.250
 Renal adipocyte volume = 0.121 = 0.654
Liver and kidney weight
 Liver weight = 0.003 < 0.001
 Kidney weight = 0.137 = 0.947
GTT and ITT
 Glucose tolerance test = 0.062 = 0.008
 Insulin tolerance test = 0.144 = 0.137
Serum hormones
 Insulin = 0.008 = 0.004
 Leptin = 0.035 = 0.349
 Adiponectin = 0.031 = 0.099

Abbreviations: ANOVA, analysis of variance; BPA, bisphenol A; DES, diethylstilbestrol; GTT, glucose tolerance test; ITT, insulin tolerance test; GD, gestation day.

aPregnant CD-1 mice were fed these doses of BPA (and DES as a positive control) in oil from GD 9 to 18, and male offspring were examined for these outcomes. The number of litters per treatment group was 14, 9, 12, 12, 11, 14, and 9, respectively. Two males per litter were examined for all outcomes except serum hormones (5-7 males from different litters). Column 1 shows results of standard linear ANOVAs using PROC GLM in SAS (controlling for litter membership). Column 2 gives P values for comparison of two nested linear regression models, with and without a [log(dose)]2 term using the R Statistical System. A significant result (indicated in bold) provides evidence that a U or inverted-U curve fits the data better than a simple linear fit, and indicates a non-monotonic dose–response function. Males were evaluated when 4 to 5 months old unless otherwise indicated. For details about the statistics, see Supplemental Materials from Angle et al.28